ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,724.30
0.00%
S&P ASX All Technology
3,092.70
0.00%
Brent Oil
82.205
-0.09%
US Dollar vs AUD
1.51378
0.00%
Bitcoin
66,701.98
0.77%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Prothena Corp. Plc - Ordinary Shares (MM) (PRTAV)

  7. Prothena Corp. Plc - Ordinary Shares (MM) (PRTAV) News

PRTAV

Prothena Corp. Plc - Ordinary Shares (MM) (PRTAV)

Prothena Corp. Plc - Ordinary Shares (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRTAV
DateTimeSourceHeadlineSymbolCompany
28/10/202207:05GlobeNewswire Inc.Prothena to Report Third Quarter 2022 Financial Results on November 3rdNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
02/09/202206:20GlobeNewswire Inc.Prothena to Participate in Upcoming Healthcare ConferencesNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
02/09/202206:05GlobeNewswire Inc.Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of DirectorsNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
09/08/202206:05GlobeNewswire Inc.Prothena Reports Second Quarter 2022 Financial Results and Business HighlightsNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
03/08/202206:05GlobeNewswire Inc.Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
02/08/202206:05GlobeNewswire Inc.Prothena to Report Second Quarter 2022 Financial Results on August 8thNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
02/07/202206:16GlobeNewswire Inc.Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
03/06/202206:05GlobeNewswire Inc.Prothena to Participate in Jefferies Healthcare ConferenceNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
06/05/202206:05GlobeNewswire Inc.Prothena Reports First Quarter 2022 Financial Results and Business HighlightsNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
29/04/202206:05GlobeNewswire Inc.Prothena to Report First Quarter 2022 Financial Results on May 5thNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
26/04/202222:30GlobeNewswire Inc.Prothena Receives FDA Fast Track Designation for PRX012, a Next-Generation Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s DiseaseNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
28/03/202223:30GlobeNewswire Inc.Prothena Announces FDA Clearance of IND for PRX012, a Subcutaneous Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s DiseaseNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
22/03/202207:05GlobeNewswire Inc.Prothena to Participate in Stifel 2022 Virtual CNS DaysNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
16/03/202220:30GlobeNewswire Inc.Prothena Presents New Data for Alzheimer’s and Parkinson’s Disease Programs at AD/PD 2022NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
18/02/202208:05GlobeNewswire Inc.Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidance and Business HighlightsNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
11/02/202208:05GlobeNewswire Inc.Prothena to Report Fourth Quarter and Full Year 2021 Financial Results and Host Webcast Conference Call on February 17, 2022NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
30/11/202108:05GlobeNewswire Inc.Prothena to Participate in JMP Securities Hematology and Oncology SummitNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
05/11/202107:05GlobeNewswire Inc.Prothena Reports Third Quarter 2021 Financial Results and Business HighlightsNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
29/10/202107:05GlobeNewswire Inc.Prothena to Report Third Quarter 2021 Financial Results on November 4thNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
02/10/202106:30GlobeNewswire Inc.Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
02/10/202106:05GlobeNewswire Inc.Prothena Announces Executive AppointmentsNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
04/09/202106:05GlobeNewswire Inc.Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
02/09/202106:05GlobeNewswire Inc.Prothena to Participate in Upcoming September Healthcare ConferencesNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
06/08/202106:05GlobeNewswire Inc.Prothena Reports Second Quarter 2021 Financial Results and Business HighlightsNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
30/07/202106:05GlobeNewswire Inc.Prothena to Report Second Quarter 2021 Financial Results on August 5thNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
26/07/202123:00GlobeNewswire Inc.Prothena Presents New Data from Robust Alzheimer’s Portfolio at the Alzheimer’s Association International Conference 2021NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
21/07/202106:05GlobeNewswire Inc.Prothena to Present Data from Two of its Alzheimer’s Disease Programs at the Alzheimer’s Association International Confer...NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
12/07/202121:00GlobeNewswire Inc.Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis ProgrammeNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
24/06/202122:30GlobeNewswire Inc.Prothena Announces Bristol Myers Squibb Opt-in of Anti-Tau PRX005 as the First Program from Global Neuroscience Research and ...NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
11/06/202104:18GlobeNewswire Inc.Prothena to Participate in JMP Securities Life Sciences Conference on June 16NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
 Showing the most relevant articles for your search:NASDAQ:PRTAV

Your Recent History

NYSE
XOM
Exxon Mobil
ASX
TLS
Telstra
ASX
QBE
QBE Insurance
FTSE
UKX
FTSE 100
ASX
WDC
Westfield
ASX
XJO
S&P ASX 200
NASDAQ
MSFT
Microsoft
ASX
NAB
National Australia Bank
ASX
XMM
S&P ASX 300 Metals and M...
ASX
ORG
Origin Energy
NASDAQ
AMZN
Amazon.com
FX
GBPAUD
Sterling vs AUD
FX
AUDJPY
AUD vs Yen
ASX
SUN
Suncorp
ASX
FMG
Fortescue
FX
EURAUD
Euro vs AUD
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved